Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $10.7 million.

  • Viemed Healthcare's Free Cash Flow rose 51566.27% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 5333.14%. This contributed to the annual value of $1.3 million for FY2024, which is 9310.63% down from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Free Cash Flow is $10.7 million, which was up 51566.27% from $4.1 million recorded in Q2 2025.
  • Viemed Healthcare's Free Cash Flow's 5-year high stood at $10.7 million during Q3 2025, with a 5-year trough of -$12.6 million in Q1 2025.
  • In the last 5 years, Viemed Healthcare's Free Cash Flow had a median value of $2.0 million in 2021 and averaged $1.6 million.
  • Per our database at Business Quant, Viemed Healthcare's Free Cash Flow tumbled by 32293.68% in 2022 and then surged by 51566.27% in 2025.
  • Quarter analysis of 5 years shows Viemed Healthcare's Free Cash Flow stood at $2.0 million in 2021, then rose by 6.02% to $2.1 million in 2022, then soared by 153.41% to $5.4 million in 2023, then plummeted by 40.99% to $3.2 million in 2024, then soared by 239.8% to $10.7 million in 2025.
  • Its Free Cash Flow stands at $10.7 million for Q3 2025, versus $4.1 million for Q2 2025 and -$12.6 million for Q1 2025.